Skeletal-related events in urological cancer patients with bone metastasis: A multicenter study in Japan-Reference-Cited by-同舟云学术

Skeletal-related events in urological cancer patients with bone metastasis: A multicenter study in Japan

Published:2010-04 Issue:4 Volume:17 Page:332-336
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:

Author:

Yokomizo Akira,Koga Hirofumi,Shinohara Nobuo,Miyahara Tsukasa,Machida Noriko,Tsukino Hiromasa,Uozumi Jiro,Nishiyama Kenryu,Satoh Fuminori,Sakai Hideki,Naito Seiji

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-2042.2010.02468.x/fullpdf

Reference12 articles.

1. A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma;Saad;J. Natl. Cancer Inst.,2002

2. Zoledronic acid delays the onset of skeletal-related events and progression of skeletal disease in patients with advanced renal cell carcinoma;Lipton;Cancer,2003

3. Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group;Berenson;N. Engl. J. Med.,1996

4. Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate;Hortobagyi;J. Clin. Oncol.,1998

5. Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group;Theriault;J. Clin. Oncol.,1999

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone metastases from urothelial carcinoma. The dark side of the moon;Journal of Bone Oncology;2021-12

2. Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) in urological malignancies: a multi-center retrospective study;Journal of Bone and Mineral Metabolism;2021-03-11

3. Antiresorptive agent-related osteonecrosis of the jaw in prostate cancer patients with bone metastasis treated with bone-modifying agents;Journal of Bone and Mineral Metabolism;2020-09-04

4. A phase II study of palliative radiotherapy combined with zoledronic acid hydrate for metastatic bone tumour from renal cell carcinoma;Japanese Journal of Clinical Oncology;2020-09-01